News | June 14, 2024
Suven to acquire a majority stake in CDMO player ‘Sapala Organics’
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Accelerating sustainability in Indian pharma industry
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Subscribe To Our Newsletter & Stay Updated
